See All Slides - tctmd.com

Slides

Presentation TCT 2014

BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) ? 2 Year___

Presenter: Rafael Ruiz-Salmeron

September 16, 2014

Presentation TCT 2014

Assessment of Biocompatibility of the Multilayer Flow Modulator with Varying Thread Numbers

Presenter: Edel Kavanagh

September 16, 2014

Presentation TCT 2014

Long-term Costs of Directional Atherectomy vs_ Other Treatment Choices for Diabetes Patients with Peripheral Artery Disease: a 24-Month Analysis of Administrative Claims Data

Presenter: Khusrow Niazi

September 16, 2014

Presentation TCT 2014

Feasibility of Radial Artery re-puncture for trans-radial procedures

Presenter: PABLO KANTOR

September 16, 2014

Presentation TCT 2014

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Presenter: George Hanzel

September 16, 2014

Presentation TCT 2014

First Percutaneous Transluminal Caval flow Restriction in a Patient with Congestive Heart Failure_

Presenter: Jose Herrera

September 16, 2014

Presentation TCT 2014

Comparison of patient, procedural characteristics and clinical outcome of Japanese and non-Japanese cohort undergoing current practice of percutaneous coronary intervention:___

Presenter: Shigeru Saito

September 16, 2014

Presentation TCT 2014

The Clinical SYNTAX score has an additive predictive value in high risk patients

Presenter: Jeehoon Kang

September 16, 2014

Presentation TCT 2014

Dedicated Bifurcation BiOSS® Stent In The Treatment Of Distal Left Main Stem Stenosis ? International Registry_

Presenter: Jacek Bil

September 16, 2014

Presentation TCT 2014

Myocardial Injury Following Transcatheter Aortic Valve Implantation: Insights from Delayed-Enhancement Cardiovascular Magnetic Resonance_

Presenter: Henrique Ribeiro

September 16, 2014

Advertisement

Slides

BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) ? 2 Year___

Assessment of Biocompatibility of the Multilayer Flow Modulator with Varying Thread Numbers

Long-term Costs of Directional Atherectomy vs_ Other Treatment Choices for Diabetes Patients with Peripheral Artery Disease: a 24-Month Analysis of Administrative Claims Data

Feasibility of Radial Artery re-puncture for trans-radial procedures

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

First Percutaneous Transluminal Caval flow Restriction in a Patient with Congestive Heart Failure_

Comparison of patient, procedural characteristics and clinical outcome of Japanese and non-Japanese cohort undergoing current practice of percutaneous coronary intervention:___

The Clinical SYNTAX score has an additive predictive value in high risk patients

Dedicated Bifurcation BiOSS® Stent In The Treatment Of Distal Left Main Stem Stenosis ? International Registry_

Myocardial Injury Following Transcatheter Aortic Valve Implantation: Insights from Delayed-Enhancement Cardiovascular Magnetic Resonance_

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content